Check out this graphic overview of the Eversense CGM system and how it works to lighten your load.

This video gives you an overview of the Eversense 90-day CGM system.

Learn more about how continuous glucose monitoring works and its benefits, with this self-paced and interactive module.

Get started with your new Eversense 90-day, CGM system… and be unstoppable!

Learn where to get adhesive patches and how to give your transmitter some personal flair with Pump Peelz.

Get started on your eversense journey…

Get a full understanding of how to initialize, care for and live happily with your new Eversense CGM.

Learn how your Eversense CGM System lets you be flexible with your alert and target settings.

Non-adjunctive use with the Eversense App – iOS 6.2.103 and Android 2.2.104

Print this card and keep it with you in your purse or wallet.

Get helpful reports that allow you to track your blood sugar levels over time and monitor how well you are meeting your target goals. These will help you keep your blood sugar more stable and provide input for your healthcare provider in making treatment decisions.

The Eversense DMS is a web-based application that lets you see the big picture—with automatic uploads from your mobile app. It stores your data and offers detailed reports to show trends and patterns over time¹.

1. The Eversense Data Management System does not provide medical advice. Changes to your treatment plan should only be made by your health care provider.

Traveling for fun or taking a business trip? Traveling with your Eversense CGM is easy - follow these two steps for a worry-free trip.

Blood sugar levels can be unpredictable. Your CGM system has two optional alert settings that give you a heads up when your levels are headed in the wrong direction, so you have time to take action.

If you see “No transmitter connected” when using your app, this quick guide will help you troubleshoot and get up and running again.

If you see “No transmitter connected” when using your app, this quick guide will help you troubleshoot and get up and running again.

Non-adjunctive use with the Eversense App – iOS 6.2.103 and Android 2.2.104

Lean how to use the Eversense ‘NOW’ user app, which lets you share your blood sugar data with friends, family or your healthcare professional.

The PRECISE, 180-day clinical trial was performed at 7 clinical sites in Europe and included 71 participants with Type 1 and Type 2 diabetes. Results demonstrated the safety and accuracy of the Eversense under-the-skin CGM system and supported it as an alternative to transcutaneous CGM.

The second study (Precise II) included 90 participants with Type 1 and Type 2 diabetes. It was performed in the United States and demonstrated the efficacy and safety of the Eversense CG System during 90 days of continuous sensor wear.

This European study included 51 participants with Type 1 and Type 2 diabetes. It showed that the Eversense CGM with under-the-skin sensor was widely accepted by users and favorably evaluated by a high percentage of participants in the study.